Skip to main content
. 2020 Nov 27;89(2):304–314. doi: 10.1002/ana.25956

TABLE 5.

Adverse Events

Event Events, n (events per patient) p, Preventive vs Conventional
Preventive Treatment, n = 25 Conventional Treatment, n = 29 Patient with no EA and No Seizures, n = 7 Patients with Seizures prior to EA, n = 22 Patients with Discordant EEG Analysis or Who Dropped Out before Treatment Allocation, n = 11
All adverse events 20 (0.80) 36 (1.24) 2 (0.29) 40 (1.82) 5 (0.45) 0.153
Serious adverse events 11 (0.44) 23 (0.79) 0 37 (1.68) 1 (0.09) 0.132
All serious adverse events
Death 0 1 (0.03) a 0 0 0 1
Status epilepticus 2 (0.08) 7 (0.24) 0 20 (0.9) 1 (0.09) 0.12
Febrile seizures 2 (0.08) 5 (0.17) 0 2 (0.09) 0 0.22
Surgery due to epilepsy 1 (0.04) 1 (0.03) 0 11 (0.5) 0 1
Upper respiratory tract infection 2 (0.08) 4 (0.14) 1 (0.14) 3 (0.14) 0 0.503
Pneumonia 2 (0.08) 2 (0.07) 0 1 (0.04) 0 0.878
Renal failure 0 1 (0.03) 0 0 0 1
Surgery due to kidney tumors 1 (0.04) 1 (0.03) 0 0 0 1
Surgery due to cardiac tumors 1 (0.04) 1 (0.03) 0 0 0 1
Nonserious adverse events reported twice or more
Upper respiratory tract infection 2 (0.08) 2 (0.07) 0 2 (0.09) 2 (0.18) 0.878
Cardiac arrhythmia 3 (0.12) 4 (0.14) 1 (0.14) 2 (0.09) 1 (0.09) 0.846
Feeding problems 1 (0.04) 1 (0.03) 0 1 (0.04) 0 1
Anemia 0 1 (0.03) 0 0 1 (0.09) 1
Constipation 0 2 (0.07) 0 1 (0.04) 0 0.494
Influenza 1 (0.04) 2 (0.07) 0 0 0 0.646
Skin hyperkeratosis 1 (0.04) 1 (0.03) 0 0 0 1
Growth of SEGA 1 (0.04) 0 0 1 (0.04) 0 0.463

Analysis includes the patients who dropped out from the study (n = 8) and patients with discordant EEG assessments (n = 7). Patients receiving preventive treatment were pooled from RCT and OLT. Patients receiving conventional treatment were pooled from RCT and OLT.

a

Due to cardiac arrest during epilepsy surgery.

EA = epileptiform activity; EEG = electroencephalogram; OLT = open‐label trial; RCT = randomized controlled trial; SEGA = subependymal giant cell astrocytoma.